Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 4822.40, up by 41.80 points or 0.87% from its previous closing of Rs. 4780.60 on the BSE.

The scrip opened at Rs. 4850.00 and has touched a high and low of Rs. 4877.00 and Rs. 4784.20 respectively. So far 57367 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3613.45 on 18-May-2020.

Last one week high and low of the scrip stood at Rs. 5200.00 and Rs. 4661.35 respectively. The current market cap of the company is Rs. 80872.29 crore.

The promoters holding in the company stood at 26.73%, while Institutions and Non-Institutions held 43.86% and 29.41% respectively.

Dr. Reddy's Laboratories has received approval from expert panel for emergency use of Russia's covid-19 vaccine Sputnik V in the India, with certain conditions. The Drugs Controller General of India (DCGI) will take a final call on the recommendation. If approved, it will be the third covid-19 vaccine to be available in India. The vaccine would be imported from Russia for emergency use in the country.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.